Celularity Inc. entered into a private placement agreement on October 24, 2025, to issue Series A Convertible Preferred Stock and warrants, totaling up to $6.67 million, with the first tranche of $2 million closing on the same date. This includes securities being sold at a 10% discount and aims to fund working capital and corporate purposes.